Total raised
$3.8M
Last: Undisclosed 2007-07
Stage
Mature
Founded
2007
Headcount
109
HQ
Petah Tikva
Sector
Health Tech & Life Sciences
About
Isotopia Molecular Imaging is a global pharmaceutical company that develops, produces, and distributes diagnostic and therapeutic radioactive isotopes and advanced PET and SPECT radiotracers.
Its flagship product, the radioisotope Lutetium-177 (both C.A and N.C.A), has attracted considerable attention and exhibited great promise in treating a variety of late-stage cancers, including metastatic prostate cancer and neuroendocrine tumors.
Its production facilities include an advanced nuclear pharmacy that provides radionuclide labelled compounds for PET/SPECT imaging, a cyclotron facility, and an aseptic manufacturing plant that also offers contract manufacturing services (CMO).
Funding history · 1 round · $3.8M total
2007-07
Undisclosed
$3.8M
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
Simulation & ImagingBiologicalsMolecules
Target customers
Healthcare & Life SciencesHealthcareLife SciencesPharmaceuticalsMedical Devices IndustryMedical Equipment
Business model
B2B
Highlights
1 PatentsVerified
Tags
precision-medicinecancer-therapycancertargeted-cancer-therapyradiologyscanningradiopharmaceuticalshospitalspharma-companiesdoctorshealthcare-providerscancer-diagnosticscancer-researchpharmaceuticalsclinical-trialsbioconvergence